Gilead to Share 4 AIDS and Hepatitis Drugs With Patent Pool - NYTimes.com
►http://www.nytimes.com/2011/07/12/health/12global.html?_r=1
In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool.
(...)
“This is a great achievement,” said James P. Love, a campaigner for lower drug prices who first proposed a pool in 2002. “The other drug companies didn’t want Gilead to sign anything, and this will put pressure on them.”